The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Südhof, T. C. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131412 · Cited by 2,547
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014
Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864
Cognitive neuroscience of emotional memory
LaBar, K. S., & Cabeza, R. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1825 · Cited by 1,834 · cited 1×
“The adrenergic system is hypothesized to affect cognition and emotion, although very few pharmacogenetic studies have reported any genetic variation that contributes to treatment response”
Backgroundthe GIANT Consortium (2009) · Nature Genetics · doi:10.1038/ng.287 · Cited by 1,720
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Non–coding RNA genes and the modern RNA world
Eddy, S. R. (2001) · Nature Reviews Genetics · doi:10.1038/35103511 · Cited by 1,426
Thorleifsson, G., Walters, G. B., Gudbjartsson, D. F., Steinthorsdottir, V., Sulem, P., Helgadottir, A., Styrkarsdottir, U., Gretarsdottir, S., Thorlacius, S., Jonsdottir, I., et al. (2009) · Nature Genetics · doi:10.1038/ng.274 · Cited by 1,375
Meltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,349
Common variants near MC4R are associated with fat mass, weight and risk of obesity
The Prostate, L., Loos, R. J. F., KORA, Study, N. H., Initiative, D. G., Study, T. S., The Wellcome Trust Case Control Consortium, FUSION, Lindgren, C. M., Li, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.140 · Cited by 1,325
A role for melanin-concentrating hormone in the central regulation of feeding behaviour
Qu, D., Ludwig, D. S., Gammeltoft, S., Piper, M., Pelleymounter, M. A., Cullen, M. J., Mathes, W. F., Przypek, J., Kanarek, R., & Maratos-Flier, E. (1996) · Nature · doi:10.1038/380243a0 · Cited by 1,319
Mice lacking melanin-concentrating hormone are hypophagic and lean
Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S., & Maratos-Flier, E. (1998) · Nature · doi:10.1038/25341 · Cited by 1,151
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140
Kapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.514 · Cited by 1,090
Regulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010
Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.3.205 · Cited by 930
Association of a human G-protein β3 subunit variant with hypertension
Siffert, W., Rosskopf, D., Siffert, G., Busch, S., Moritz, A., Erbel, R., Sharma, A. M., Ritz, E., Wichmann, H.-E., Jakobs, K. H., et al. (1998) · Nature Genetics · doi:10.1038/ng0198-45 · Cited by 726
Jönsson, E. G., Nöthen, M. M., Grünhage, F., Farde, L., Nakashima, Y., Propping, P., & Sedvall, G. C. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000532 · Cited by 721
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Nasrallah, H. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002066 · Cited by 714
Meyre, D., Delplanque, J., Chèvre, J.-C., Lecoeur, C., Lobbens, S., Gallina, S., Durand, E., Vatin, V., Degraeve, F., Proença, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.301 · Cited by 652
Dopamine D4 receptors elevated in schizophrenia
Seeman, P., Guan, H.-C., & Van Tol, H. H. M. (1993) · Nature · doi:10.1038/365441a0 · Cited by 628
BDNF function and intracellular signaling in neurons.
Numakawa, T., Suzuki, S., Kumamaru, E., Adachi, N., Richards, M., & Kunugi, H. (2010) · PubMed · doi:10.14670/hh-25.237 · Cited by 597
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
The International HapMap Project Web site: Figure 1.
Thorisson, G. A., Smith, A. V., Krishnan, L., & Stein, L. D. (2005) · Genome Research · doi:10.1101/gr.4413105 · Cited by 585
Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study
McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · British Journal of Psychiatry · doi:10.1192/03-162 · Cited by 546
The Search for Human Obesity Genes
Comuzzie, A. G., & Allison, D. B. (1998) · Science · doi:10.1126/science.280.5368.1374 · Cited by 544
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Nordström, A.-L., Farde, L., Wiesel, F.-A., Forslund, K., Pauli, S., Halldin, C., & Uppfeldt, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90288-o · Cited by 527
Novel antipsychotics: comparison of weight gain liabilities.
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · PubMed · Cited by 523
Hypothalamic serotonin in control of eating behavior, meal size, and body weight
Leibowitz, S. F., & Alexander, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00186-3 · Cited by 507
Marder, S. R., McQuade, R. D., Stock, E., Kaplita, S., Marcus, R., Safferman, A. Z., Saha, A., Ali, M., & Iwamoto, T. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00050-1 · Cited by 467
Arinami, T. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.577 · Cited by 455
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., & Carr, V. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.88 · Cited by 453
Farooqi, I. S., & O'Rahilly, S. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144924 · Cited by 440
Gratacòs, M., González, J. R., Mercader, J. M., de Cid, R., Urretavizcaya, M., & Estivill, X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.025 · Cited by 428
Kim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394
Novel Antipsychotics: Comparison of Weight Gain Liabilities
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0602 · Cited by 393
Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
Newcomer, J. W. (2007) · PubMed · Cited by 380
Endocannabinoids and the control of energy balance
Matias, I., & Di Marzo, V. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.11.006 · Cited by 365
SIFFERT, W., FORSTER, P., JÖCKEL, K.-H., MVERE, D. A., BRINKMANN, B., NABER, C., CROOKES, R., HEYNS, A. D. P., EPPLEN, J. T., FRIDEY, J., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1091921 · Cited by 334
Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia
Kapur, S., & Remington, G. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.503 · Cited by 324
SNAP-25 is expressed in islets of Langerhans and is involved in insulin release.
Sadoul, K., Lang, J., Montecucco, C., Weller, U., Regazzi, R., Catsicas, S., Wollheim, C. B., & Halban, P. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.1019 · Cited by 247
Effects of Clozapine on Plasma Cytokine and Soluble Cytokine Receptor Levels
Pollmacher, T., Hinze-Selch, D., & Mullington, J. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00011 · Cited by 232
Hoffstedt, J., Eriksson, P., Mottagui-Tabar, S., & Arner, P. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-33466 · Cited by 222
Yuan, X., Yamada, K., Ishiyama-Shigemoto, S., Koyama, W., & Nonaka, K. (2000) · Diabetologia · doi:10.1007/s001250050056 · Cited by 219
Dubern, B., Clément, K., Pelloux, V., Froguel, P., Girardet, J.-P., Guy-Grand, B., & Tounian, P. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116284 · Cited by 194
Weight effects associated with antipsychotics: A comprehensive database analysis
Parsons, B., Allison, D. B., Loebel, A., Williams, K., Giller, E., Romano, S., & Siu, C. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.025 · Cited by 191
D2 dopamine receptor gene and obesity
Noble, E. P., Noble, R. E., Ritchie, T., Syndulko, K., Bohlman, M. C., Noble, L. A., Zhang, Y., Sparkes, R. S., & Grandy, D. K. (1994) · International Journal of Eating Disorders · doi:10.1002/1098-108x(199404)15:3<205::aid-eat2260150303>3.0.co;2-p · Cited by 191
Nebert, D. W., Zhang, G., & Vesell, E. S. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952864 · Cited by 181
Nagamatsu, S., Nakamichi, Y., Yamamura, C., Matsushima, S., Watanabe, T., Ozawa, S., Furukawa, H., & Ishida, H. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2367 · Cited by 179
Hirvonen, M. M., Laakso, A., Någren, K., Rinne, J. O., Pohjalainen, T., & Hietala, J. (2009) · Synapse · doi:10.1002/syn.20672 · Cited by 176
Pharmacologic treatment of schizophrenia
Kane, J. M., & Correll, C. U. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/jkane · Cited by 176
Gebhardt, S., Haberhausen, M., Heinzel-Gutenbrunner, M., Gebhardt, N., Remschmidt, H., Krieg, J.-C., Hebebrand, J., & Theisen, F. M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.001 · Cited by 174
Neurotrophins and schizophrenia
Buckley, P. F., Mahadik, S., Pillai, A., & Terry, A. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.025 · Cited by 166
Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing, D. A. (2004) · PubMed · Cited by 162
Changes in body mass index for individuals with and without schizophrenia, 1987–1996
Homel, P., Casey, D., & Allison, D. B. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00256-0 · Cited by 160
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
Adkins, D. E., Åberg, K. A., McClay, J. L., Bukszár, J., Zhao, Z., Jia, P., Stroup, T. S., Perkins, D. O., McEvoy, J. P., Lieberman, J. A., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.14 · Cited by 150
Cordeira, J., Frank, L., Sena‐Esteves, M., Pothos, E. N., & Rios, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5768-09.2010 · Cited by 147
Risperidone-related Weight Gain: Genetic and Nongenetic Predictors
Lane, H., Liu, Y., Huang, C., Chang, Y., Wu, P.-L., Lu, C. ‐., & Chang, W. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203196.65710.2b · Cited by 147
Dopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHD
Stein, M. A., Waldman, I. D., Sarampote, C. S., Seymour, K. E., Robb, A. S., Conlon, C. J., Kim, S., & Cook, E. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300718 · Cited by 146
The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment
Reynolds, G. P., Templeman, L. A., & Zhang, Z. J. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.019 · Cited by 143
Genetics of Antipsychotic Treatment Emergent Weight Gain in Schizophrenia
Müller, D. J., & Kennedy, J. L. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.6.863 · Cited by 139
Self-citationSentissi, O., Epelbaum, J., Olié, J., & Poirier, M. F. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm141 · Cited by 136
Dong, Y., Zhu, H., Sagnella, G. A., Carter, N. D., Cook, D. G., & Cappuccio, F. P. (1999) · Hypertension · doi:10.1161/01.hyp.34.6.1193 · Cited by 132
Comings, D. E., Gade, R., MacMurray, J. P., Muhleman, D. R., & Peters, W. R. (1996) · PubMed · Cited by 127
Szekeres, G., Kéri, S., Juhász, A., Rimanóczy, Á., Szendi, I., Czimmer, C., & Janka, Z. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20045 · Cited by 126
Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release
King, P., Williams, G. H., Doods, H. N., & Widdowson, P. S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00230-2 · Cited by 124
Molecular Genetics of Human Obesity‐Associated MC4R Mutations
Lubrano-Berthelier, C., Cavazos, M. M., Dubern, B., Shapiro, A., Stunff, C. L., Zhang, S., Picart, F., Govaerts, C., Froguel, P., Bougneres, P. F., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03161.x · Cited by 122
Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis
Luca, V. D., Müller, D. J., de Bartolomeis, A., & Kennedy, J. L. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007547 · Cited by 119
Self-citationHauner, H., Meier, M., ckel, K.-H. J., Frey, U. H., & Siffert, W. (2003) · Pharmacogenetics · doi:10.1097/00008571-200308000-00003 · Cited by 114
Laika, B., Leucht, S., Heres, S., Schneider, H., & Steimer, W. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.32 · Cited by 110
Zhang, X., Zhou, D. F., Wu, G. Y., Cao, L. Y., Tan, Y. L., Haile, C. N., Li, J., Lü, L., Kosten, T. A., & Kosten, T. R. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301619 · Cited by 108
Tiwari, A. K., Zai, C. C. H., Likhodi, O., Lisker, A., Singh, D., de Souza, R. P., Batra, P., Zaidi, S. H. E., Chen, S., Liu, F., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.235 · Cited by 108
Self-citationBuckland, P. R., Hoogendoorn, B., Guy, C., Smith, S. K., Coleman, S. L., & O’Donovan, M. C. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.613 · Cited by 108
Ellingrod, V. L., Miller, D. D., Taylor, S. F., Moline, J., Holman, T. L., & Kerr, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.030 · Cited by 107
Hellard, S. L., Theisen, F., Haberhausen, M., Raeder, M. B., Fernø, J., Gebhardt, S., Hinney, A., Remschmidt, H., Krieg, J. C., Mehler‐Wex, C., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002133 · Cited by 106
Polymorphisms of the HTR2C Gene and Antipsychotic-Induced Weight Gain: An Update and Meta-Analysis
Sicard, M. N., Zai, C. C. H., Tiwari, A. K., de Souza, R. P., Meltzer, H. Y., Lieberman, J. A., Kennedy, J. L., & Müller, D. J. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.123 · Cited by 103
Self-citationG-protein β3 Subunit Gene Splice Variant and Body Fat Distribution in Nunavut InuitPreprint
Hegele, R. A., Anderson, C. M., Young, T. K., et al. (1999) · Genome Research · doi:10.1101/gr.9.10.972 · Cited by 103
BDNF Val66Met Polymorphism Is Associated with Body Mass Index in Healthy Adults
Gunstad, J., Schofield, P. R., Paul, R. H., Spitznagel, M. B., Cohen, R. A., Williams, L. M., Kohn, M. R., & Gordon, E. (2006) · Neuropsychobiology · doi:10.1159/000093341 · Cited by 102
Bodyweight Gain Associated with Atypical Antipsychotics: Epidemiology and Therapeutic Implications
Russell, J. M., & Mackell, J. A. (2001) · CNS Drugs · doi:10.2165/00023210-200115070-00004 · Cited by 102
Pharmacogenetics of antipsychotic-induced weight gain
Correll, C. U., & Malhotra, A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1949-9 · Cited by 94
Mulder, H., Franke, B., van der, A. A. V. D. B., Arends, J., Wilmink, F. W., Scheffer, H., & Egberts, T. C. G. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3180a76dc0 · Cited by 94
Gunes, A., Melkersson, K. I., Scordo, M. G., & Dahl, M. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819302c3 · Cited by 93
Gebhardt, S., Theisen, F., Haberhausen, M., Heinzel‐Gutenbrunner, M., Wehmeier, P. M., Krieg, J. C., Kühnau, W., Schmidtke, J., Remschmidt, H., & Hebebrand, J. (2009) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01084.x · Cited by 91
Fernø, J., Skrede, S., Vik‐Mo, A. O., Håvik, B., & Steen, V. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-69 · Cited by 91
Müller, D. J., Klempan, T., Luca, V. D., Sicard, T., Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J., Citrome, L., McEvoy, J. P., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.037 · Cited by 91
Self-citationPolymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication
Gregoor, J. G., van der Weide, J., Mulder, H., Cohen, D., van Megen, H. J. G. M., Egberts, T. C. G., & Heerdink, E. R. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819359be · Cited by 87
Yevtushenko, O. O., Cooper, S. J., O'Neill, R., Doherty, J. K., Woodside, J. V., & Reynolds, G. P. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.041723 · Cited by 87
Hengstenberg, C. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00292-3 · Cited by 84
HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia
Mulder, H., Cohen, D., Scheffer, H., Wied, C. C. G., Arends, J., Wilmink, F. W., Franke, B., & Egberts, T. C. G. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181934462 · Cited by 82
Lencz, T., Robinson, D. G., Napolitano, B. A., Sevy, S. M., Kane, J. M., Goldman, D. A., & Malhotra, A. K. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ca24b · Cited by 81
Pharmacogenomics: The Promise of Personalized Medicine for CNS Disorders
de León, J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.147 · Cited by 81
Levitan, R. D., Masellis, M., Lam, R. W. M., Kaplan, A. S., Davis, C. A., Tharmalingam, S., Mackenzie, B. E., Basile, V. S., & Kennedy, J. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301121 · Cited by 80
Self-citationAssociation study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients
Zai, C. C. H., Hwang, R., Luca, V. D., Müller, D. J., King, N. A., Zai, G. C., Remington, G. J., Meltzer, H. Y., Lieberman, J. A., Potkin, S. G., et al. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007152 · Cited by 80
Self-citationGodlewska, B. R., Olajossy-Hilkesberger, L., Ciwoniuk, M., Olajossy, M., Marmurowska-Michałowska, H., Limon, J., & Landowski, J. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.18 · Cited by 79
Lipska, B. K., Lerman, D. N., Khaing, Z. Z., & Weinberger, D. R. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03047.x · Cited by 79
Pharmacogenetics of antipsychotic-induced weight gain
Müller, D., Muglia, P., Fortune, T., & Kennedy, J. L. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.05.001 · Cited by 78
Self-citationA DRD4/BDNF gene–gene interaction associated with maximum BMI in women with bulimia nervosa
Kaplan, A. S., Levitan, R. D., Yilmaz, Z., Davis, C., Tharmalingam, S., & Kennedy, J. L. (2008) · International Journal of Eating Disorders · doi:10.1002/eat.20474 · Cited by 77
Self-citationOpgen‐Rhein, C., Brandl, E. J., Müller, D. J., Neuhaus, A. H., Tiwari, A. K., Sander, T., & Dettling, M. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.50 · Cited by 77
Self-citationRyu, S., Cho, E. Y., Park, T., Oh, S., Jang, W.-S., Kim, S.-K., Lee, D., & Hong, K. S. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.021 · Cited by 76
Park, Y., Chung, Y.-C., Lee, S., Lee, K., Kim, H., Byun, Y., Lim, S., Paik, J., & Lee, H. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30311 · Cited by 75
Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers
Ghotbi, R., Gomez, A. V., Milani, L. A., Tybring, G., Syvänen, A., Bertilsson, L., Ingelman‐Sundberg, M., & Aklillu, E. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.4 · Cited by 74
G-protein β3 subunit 825T allele and hypertension
Siffert, W. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0010-4 · Cited by 73
Wu, S., Xing, Q., Gao, R., Li, X., Gu, N., Feng, G., & He, L. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.014 · Cited by 72
Ellingrod, V. L., PharmD, Bcpp, Bishop, J. R., PharmD, Bartolomé Iglesias, S., Moline, J., MS, M., Lin, Y., Rush, A. J., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4131 · Cited by 71
Serotonin receptor 2C and mental disorders: Genetic, expression, and RNA editing studies
Iwamoto, K., Bundo, M., & Kato, T. (2009) · RNA Biology · doi:10.4161/rna.6.3.8370 · Cited by 69
Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
Müller, D., Zai, C. C. H., Sicard, M. N., Remington, E., de Souza, R. P., Tiwari, A. K., Hwang, R., Likhodi, O., Shaikh, S. A., Freeman, N., et al. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.65 · Cited by 69
Self-citation5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine
Travis, M. J., Busatto, G. F., Pilowsky, L. S., Mulligan, R. S., Acton, P. D., Gacinovic, S., Mertens, J. J. R., Terriere, D., Costa, D. C., Ell, P. J., et al. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.3.236 · Cited by 68
Chagnon, Y. C., Mérette, C., Bouchard, R.-H., Émond, C., Roy, M.-A., & Maziade, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001537 · Cited by 67
Pharmacogenetics of antipsychotic-induced side effects
Lencz, T., & Malhotra, A. K. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.4/tlencz · Cited by 67
Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients
Ruaño, G., Goethe, J. W., Caley, C. F., Woolley, S. B., Holford, T. R., Kocherla, M., Windemuth, A., & de León, J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001944 · Cited by 66
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders
Drago, A., & Serretti, A. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30864 · Cited by 66
Davis, C., Levitan, R. D., Kaplan, A. S., Carter, J., Reid, C., Curtis, C., Patte, K., & Kennedy, J. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301348 · Cited by 65
Self-citationEffect of the (C825T) Gβ3 Polymorphism on Adrenoceptor-Mediated Lipolysis in Human Fat Cells
Rydén, M., Faulds, G., Hoffstedt, J., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1601 · Cited by 65
Defective Melanocortin 4 Receptors in Hyperphagia and Morbid Obesity
List, J. F., & Habener, J. F. (2003) · New England Journal of Medicine · doi:10.1056/nejme030013 · Cited by 62
Kuzman, M. R., Medved, V., Božina, N., Hotujac, L., Šain, I., & Bilusic, H. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.06.006 · Cited by 62
Metabolic Abnormalities and the Role of Leptin in Human Obesity
Pi‐Sunyer, F. X., & Laferrère, B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5392-1 · Cited by 62
Genetics of Antipsychotic-induced Side Effects and Agranulocytosis
Chowdhury, N. I., Remington, G. J., & Kennedy, J. L. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0185-3 · Cited by 61
Self-citationZhang, X., Tan, Y. L., Zhou, D. F., Haile, C. N., Cao, L. Y., Xu, Q., Shen, Y., Kosten, T. A., & Kosten, T. R. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3180582412 · Cited by 61
Gentile, S. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00589.x · Cited by 61
Antipsychotics and Schizophrenia: From Efficacy and Effectiveness to Clinical Decision-Making
Foussias, G., & Remington, G. J. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500302 · Cited by 59
Mihara, K., Kondo, T., Yasui‐Furukori, N., et al. (2003) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200306000-00006 · Cited by 58
Grossman, I., Sullivan, P. F., Walley, N., Liu, Y., Dawson, J. R., Gumbs, C. E., Gaedigk, A., Leeder, J. S., McEvoy, J. P., Weale, M. E., et al. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e3181863239 · Cited by 57
Kang, S., Lee, H., Park, Y. M., Choi, J.-E., Han, C., Kim, Y., Kim, S., Lee, M.-S., Joe, S.-H., Jung, I., et al. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.002 · Cited by 55
Lin, Y., Ellingrod, V. L., Bishop, J. R., & Miller, D. D. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000246761.82377.a6 · Cited by 54
Mulder, H., Franke, B., van der, A. A. V. D. B., Arends, J., Wilmink, F. W., Egberts, T. C. G., & Scheffer, H. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500422 · Cited by 54
5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity
Hill, M., & Reynolds, G. P. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.038 · Cited by 53
Zai, G. C., Müller, D. J., Volavka, J., Czobor, P., Lieberman, J. A., Meltzer, H. Y., & Kennedy, J. L. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0482-4 · Cited by 50
Self-citationSickert, L., Müller, D. J., Tiwari, A. K., Shaikh, S. A., Zai, C. C. H., de Souza, R. P., Luca, V. D., Meltzer, H. Y., Lieberman, J. A., & Kennedy, J. L. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.43 · Cited by 50
Self-citationLeptin Gene –2548G/A variants predict risperidone-associated weight gain in children and adolescents
Calarge, C. A., Ellingrod, V. L., Zimmerman, B. M., Ación, L., Sivitz, W. I., & Schlechte, J. (2009) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283328e06 · Cited by 49
Jagadish, M. N., Fernandez, C. S., Hewish, D. R., Macaulay, S. L., Gough, K. H., Grusovin, J., Verkuylen, A. J., Cosgrove, L. J., ALAFACI, A., Frenkel, M. J., et al. (1996) · Biochemical Journal · doi:10.1042/bj3170945 · Cited by 48
Pérez‐Iglesias, R., Mata, I. F., Amado, J., Berja, A., García‐Unzueta, M. T., Martínez‐García, O., Arranz, M. J., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181fae248 · Cited by 48
Park, Y.-M., Cho, J.-H., Kang, S., Choi, J. E., Lee, S.-H., Kim, L., & Lee, H. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00872.x · Cited by 46
Božina, N., Medved, V., Kuzman, M. R., Šain, I., & Sertić, J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106072750 · Cited by 45
Hong, C., Liou, Y., Bai, Y. M., Chen, T.-T., Wang, Y.-C., & Tsai, S. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283397d06 · Cited by 45
HTR2C haplotypes and antipsychotics‐induced weight gain: X‐linked multimarker analysis
Luca, V. D., Müller, D. J., Hwang, R., et al. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.868 · Cited by 43
Self-citationFunctional analysis of the ‐2548G/A leptin gene polymorphism in breast cancer cells
Terrasi, M., Fiorio, E., Mercanti, A., Koda, M., Moncada, C., Sulkowski, S., Merali, S., Russo, A. D., & Surmacz, E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24372 · Cited by 42
Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin
McCarthy, S., Mottagui‐Tabar, S., Mizuno, Y., Sennblad, B., Hoffstedt, J., Arner, P., Wahlestedt, C., & Andersson, B. (2005) · Human Genetics · doi:10.1007/s00439-005-1328-6 · Cited by 41
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients
Musil, R., Spellmann, I., Riedel, M. J., Dehning, S., Douhet, A., Maino, K., Zill, P., Müller, N., Möller, H., & Bondy, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.11.003 · Cited by 40
Gregoor, J. G., van der Weide, J., Loovers, H. M., van Megen, H. J. G. M., Egberts, T. C. G., & Heerdink, E. R. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.40 · Cited by 40
The role of neuroleptics in manic-depressive illness.
Kane, J. M. (1988) · PubMed · Cited by 40
Smith, R. C., Segman, R. H., Golcer-Dubner, T., Павлов, В. Н., & Lerer, B. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500474 · Cited by 39
Monteleone, P., Milano, W., Petrella, C., Canestrelli, B., & Maj, M. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181e742c5 · Cited by 39
Touma, C. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1271702 · Cited by 38
Tiwari, A. K., Zai, C. C. H., Meltzer, H. Y., Lieberman, J. A., Müller, D. J., & Kennedy, J. L. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1111 · Cited by 34
Self-citationA Season-of-Birth/DRD4 Interaction Predicts Maximal Body Mass Index in Women with Bulimia Nervosa
Levitan, R. D., Kaplan, A. S., Davis, C. A., Lam, R. W. M., & Kennedy, J. L. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.38 · Cited by 33
Self-citationHerken, H., Erdal, M. E., Aydın, N., Şengül, C., Karadağ, F., Barlas, O., & Akın, F. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0893 · Cited by 33
Chagnon, Y. C., Bureau, A., Gendron, D., Bouchard, R.-H., Mérette, C., Roy, M., & Maziade, M. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30554 · Cited by 33
Srivastava, V., Deshpande, S. N., Nimgaonkar, V. L., Lerer, B., & Thelma, B. K. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.8.1055 · Cited by 32
ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics
Liu, Y.-R., Loh, E.-W., Lan, T.-H., Chen, S.-F., Yu, Y., Chang, Y.-H., Huang, C.-J., Hu, T.-M., Lin, K.-M., Yao, Y., et al. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.55 · Cited by 31
Popp, J., Leucht, S., Heres, S., & Steimer, W. (2008) · The Pharmacogenomics Journal · doi:10.1038/tpj.2008.5 · Cited by 31
Kim, S. H., Nikolics, L., Abbasi, F., Lamendola, C. A., Link, J. T., Reaven, G. M., & Lindley, S. E. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.007 · Cited by 27
Wang, Y., Bai, Y., Chen, J., Lin, C., Lai, I., & Liou, Y. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1122 · Cited by 26
An investigation of the α1A‐adrenergic receptor gene and antipsychotic‐induced side‐effects
Sáiz, P. A., Susce, M. T., Clark, D. A., Kerwin, R. W., Molero, P., Arranz, M. J., & de León, J. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.903 · Cited by 24
Himmerich, H., Kaufmann, C., Schuld, A., & Pollmächer, T. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.04.012 · Cited by 19
Cited by
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Nucifora, F. C., Woznica, E., Lee, B. J., Cascella, N., & Sawa, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.016 · Cited by 304
Dietary intake of people with severe mental illness: systematic review and meta-analysis
Teasdale, S. B., Ward, P. B., Samaras, K., Firth, J., Stubbs, B., Tripodi, E., & Burrows, T. L. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.20 · Cited by 298
Cooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292
Bahr, S. M., Weidemann, B. J., Castro, A. N., Walsh, J. W., deLeon, O., Burnett, C. M. L., Pearson, N. A., Murry, D. J., Grobe, J. L., & Kirby, J. R. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.018 · Cited by 143
Metadata
- Authors
- Lett, T. A. P., Wallace, T. J. M., Chowdhury, N. I., Tiwari, A. K., Kennedy, J. L., & Müller, D. J.
- Venue
- Molecular Psychiatry
- Published
- 2011-09-06
- Volume
- 17
- Issue
- 3
- Pages
- 242-266
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2061767937
- Cited by
- 264
- References
- 157
- FWCI
- 17.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.